Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-human Primate Lymphocryptoviruses: Past, Present, and Future.

Current topics in microbiology and immunologyยท2025
Same author

Neutralizing antibodies against Epstein-Barr virus infection of B cells can protect from oral viral challenge in the rhesus macaque animal model.

Cell reports. Medicineยท2021
Same author

Species-specific functions of Epstein-Barr virus nuclear antigen 2 (EBNA2) reveal dual roles for initiation and maintenance of B cell immortalization.

PLoS pathogensยท2017
Same author

Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.

Journal of virologyยท2015
Same author

Non-human Primate Lymphocryptoviruses: Past, Present, and Future.

Current topics in microbiology and immunologyยท2015
Same author

Host Range Restriction of Epstein-Barr Virus and Related Lymphocryptoviruses.

Journal of virologyยท2015

Related Experiment Video

Updated: May 12, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Nonhuman primate models for Epstein-Barr virus infection.

Fred Wang1

  • 1Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, MCP 836, 181 Longwood Avenue, Boston, MA 02115, United States. fwang@rics.bwh.harvard.edu

Current Opinion in Virology
|April 9, 2013
PubMed
Summary

Nonhuman primate (NHP) models using rhesus lymphocryptovirus (rhLCV) offer insights into Epstein-Barr virus (EBV) infection dynamics. These models are crucial for developing novel EBV vaccines and understanding disease pathogenesis.

More Related Videos

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
06:38

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

Related Experiment Videos

Last Updated: May 12, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
06:38

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Epstein-Barr virus (EBV) infects most humans, causing diseases like mononucleosis and cancers.
  • Nonhuman primate (NHP) models are vital for studying EBV and related lymphocryptoviruses (LCVs).

Purpose of the Study:

  • To highlight progress in NHP models for EBV research.
  • To emphasize the potential of these models for EBV vaccine development.

Main Methods:

  • Cloning and sequencing of LCV prototypes.
  • Characterization of immune responses to LCV in NHPs.
  • Development of genetic manipulation systems for rhesus LCV (rhLCV).

Main Results:

  • Successful experimental LCV infections in rhesus macaques.
  • New insights into host-virus interactions during EBV infection.
  • Established platform for EBV vaccine research.

Conclusions:

  • NHP models significantly advance understanding of EBV biology.
  • Expansion of LCV-free NHP colonies is essential for future research.
  • These models are key to developing effective EBV vaccines.